Synaptogenix, Inc. (SNPX) Financials
Stock symbol SNPX is outdated, potentially delisted? Maybe it is available on other exchange?
SNPX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2023 | 32.4 million | 3.9 million |
| June 30, 2023 | 33.4 million | 6.5 million |
| March 31, 2023 | 36.5 million | 2.3 million |
| Dec. 31, 2022 | 38.6 million | 3.2 million |
SNPX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2023 | -1.2 million | 15064 |
| June 30, 2023 | -1.2 million | 334416 |
| March 31, 2023 | -1.7 million | 644781 |
| Dec. 31, 2022 | -2.8 million | 1.5 million |
SNPX Net Income
No data available :(
SNPX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2023 | 31.7 million | - | - |
| June 30, 2023 | 32.9 million | - | - |
| March 31, 2023 | 35.8 million | - | - |
| Dec. 31, 2022 | 37.5 million | - | - |
SNPX Shares Outstanding
SNPX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2023 | - | 212103 | 1.2 million | - |
| June 30, 2023 | 669 | 307211 | 1.5 million | - |
| March 31, 2023 | 2038 | 877717 | 2.0 million | - |
| Dec. 31, 2022 | 2139 | 1.4 million | 4.5 million | - |
SNPX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2023 | - | 1723 |
| June 30, 2023 | - | 1724 |
| March 31, 2023 | - | 1690 |
| Dec. 31, 2022 | - | 1526 |
SNPX
Price: $7.85
52 week price:
Earnings Per Share: -10.46 USD
P/E Ratio: -0.75
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1967
Market Capitalization: 10.9 million